News life sciences News Publications
Wednesday July 19th, 2023
Sorry, this entry is only available in Polish.
Sorry, this entry is only available in Polish.
DISTRIBUTION Possible ’faster’ export/sale of products included on the list of products facing potential shortages in Poland. The Main Pharmaceutical Inspectorate (GIF) will be able…
On the website of the Government Legislation Centre on January 2 this year, a draft act amending the act on…
The NSA allows the sale of alcohol over the Internet The Supreme Administrative Court (NSA), in a judgment dated September…
General information CBD (cannabidiol) has been steadily gaining popularity for some years now, and the global CBD market is expected…
On April 10, 2024, the European Parliament adopted an update of four of the seven so-called “breakfast directives”[1] – directives…
The Intellectual Property team at Sołtysiński Kawecki & Szlęzak has been awarded a Gold Laurel by Intellectual Asset Management magazine’s…
We are pleased to inform that veterinary clinic “Animal” located in Łódź has joined AniCura, a family of leading veterinary…
The Intellectual Property law team of Sołtysiński Kawecki & Szlęzak has been awarded a Gold Laurel in Intellectual Asset Management…
The hemp industry is not only one of the fastest growing in Poland, but also worldwide. New products made with…
On January 1, 2024, an amendment to the Public Health Act entered into force, revolutionizing the energy drinks market in…
We are pleased to announce that the „International Advertising Law: A Practical Global Guide – Second Edition” has been published by…
RESTRICTIONS ON TRADE Adding more products to the anti-export list (the requirement to report export to the Chief Pharmaceutical Inspectorate (GIF) 30 days…
In July last year, we reported that due to ongoing discussions, the possibility of limiting the sale of energy drinks…
EU regulations on medical devices (MDR[1]) and in vitro diagnostic medical devices (IVDR[2]) have been applied for several years now…
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of KO-MED Clinical Centers—one…